BMJ 2013-12-01

Role of diuretics, _ blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.

Lan Shen, BimalR Shah, EricM Reyes, Laine Thomas, Daniel Wojdyla, Peter Diem, LawrenceA Leiter, Bernard Charbonnel, Viacheslav Mareev, EdwardS Horton, StevenM Haffner, Vladimir Soska, Rury Holman, MAngelyn Bethel, Frank Schaper, Jie-Lena Sun, JohnJV McMurray, RobertM Califf, Henry Krum

Index: BMJ 347 , f6745, (2013)

Full Text: HTML

Abstract

To examine the degree to which use of _ blockers, statins, and diuretics in patients with impaired glucose tolerance and other cardiovascular risk factors is associated with new onset diabetes.

Related Compounds

Structure Name/CAS No. Articles
Nateglinide Structure Nateglinide
CAS:105816-04-4
L-Valine Structure L-Valine
CAS:72-18-4
L-Phenylalanine Structure L-Phenylalanine
CAS:63-91-2
Valsartan Structure Valsartan
CAS:137862-53-4
D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis- Structure D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis-
CAS:105816-06-6